WO2017206783A1 - 骨盆腔内膀胱底外支架和植入方法 - Google Patents
骨盆腔内膀胱底外支架和植入方法 Download PDFInfo
- Publication number
- WO2017206783A1 WO2017206783A1 PCT/CN2017/085812 CN2017085812W WO2017206783A1 WO 2017206783 A1 WO2017206783 A1 WO 2017206783A1 CN 2017085812 W CN2017085812 W CN 2017085812W WO 2017206783 A1 WO2017206783 A1 WO 2017206783A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bladder
- pubic
- pelvic
- stent
- injection channel
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- 238000002347 injection Methods 0.000 claims abstract description 65
- 239000007924 injection Substances 0.000 claims abstract description 65
- 239000003814 drug Substances 0.000 claims abstract description 48
- 210000000683 abdominal cavity Anatomy 0.000 claims abstract description 30
- 210000000056 organ Anatomy 0.000 claims abstract description 24
- 210000003689 pubic bone Anatomy 0.000 claims abstract description 14
- 238000001356 surgical procedure Methods 0.000 claims abstract description 14
- 238000005516 engineering process Methods 0.000 claims abstract description 12
- 230000006378 damage Effects 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims description 27
- 238000002513 implantation Methods 0.000 claims description 26
- 210000004061 pubic symphysis Anatomy 0.000 claims description 26
- 230000006837 decompression Effects 0.000 claims description 20
- 230000009467 reduction Effects 0.000 claims description 18
- 210000005070 sphincter Anatomy 0.000 claims description 18
- 241000282414 Homo sapiens Species 0.000 claims description 17
- 238000004088 simulation Methods 0.000 claims description 15
- 230000036760 body temperature Effects 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 210000001519 tissue Anatomy 0.000 claims description 11
- 230000003187 abdominal effect Effects 0.000 claims description 10
- 210000003041 ligament Anatomy 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000003325 tomography Methods 0.000 claims description 9
- 230000001066 destructive effect Effects 0.000 claims description 6
- 238000012084 abdominal surgery Methods 0.000 claims description 5
- 210000003029 clitoris Anatomy 0.000 claims description 5
- 210000001520 comb Anatomy 0.000 claims description 5
- 210000004303 peritoneum Anatomy 0.000 claims description 5
- 238000000053 physical method Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 4
- 210000001177 vas deferen Anatomy 0.000 claims description 4
- 238000012795 verification Methods 0.000 claims description 4
- 239000003708 ampul Substances 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 210000002758 humerus Anatomy 0.000 claims description 3
- 230000002452 interceptive effect Effects 0.000 claims description 3
- 230000002980 postoperative effect Effects 0.000 claims description 3
- 238000007639 printing Methods 0.000 claims description 3
- 210000004291 uterus Anatomy 0.000 claims description 3
- 210000001215 vagina Anatomy 0.000 claims description 3
- 210000003932 urinary bladder Anatomy 0.000 abstract description 134
- 230000006870 function Effects 0.000 abstract description 17
- 210000001835 viscera Anatomy 0.000 abstract description 17
- 238000000338 in vitro Methods 0.000 abstract description 2
- 239000012567 medical material Substances 0.000 abstract description 2
- 241000237513 Pecten Species 0.000 abstract 2
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 210000003708 urethra Anatomy 0.000 description 14
- 230000003902 lesion Effects 0.000 description 13
- 210000002700 urine Anatomy 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002307 prostate Anatomy 0.000 description 7
- 210000000664 rectum Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 230000002485 urinary effect Effects 0.000 description 5
- 238000010146 3D printing Methods 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 210000004197 pelvis Anatomy 0.000 description 4
- 206010010356 Congenital anomaly Diseases 0.000 description 3
- 210000003195 fascia Anatomy 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 238000007915 intraurethral administration Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 208000037157 Azotemia Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000001314 paroxysmal effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000003384 transverse colon Anatomy 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- 208000025962 Crush injury Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000037424 autonomic function Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000003204 ejaculatory duct Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000547 structure data Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
- A61F2/0045—Support slings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/025—Tomosynthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0022—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse placed deep in the body opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F5/00—Manufacture of workpieces or articles from metallic powder characterised by the special shape of the product
- B22F5/10—Manufacture of workpieces or articles from metallic powder characterised by the special shape of the product of articles with cavities or holes, not otherwise provided for in the preceding subgroups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C64/00—Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
- B29C64/30—Auxiliary operations or equipment
- B29C64/386—Data acquisition or data processing for additive manufacturing
- B29C64/393—Data acquisition or data processing for additive manufacturing for controlling or regulating additive manufacturing processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y50/00—Data acquisition or data processing for additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y50/00—Data acquisition or data processing for additive manufacturing
- B33Y50/02—Data acquisition or data processing for additive manufacturing for controlling or regulating additive manufacturing processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0041—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using additional screws, bolts, dowels or rivets, e.g. connecting screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/002—Designing or making customized prostheses
- A61F2240/004—Using a positive or negative model, e.g. moulds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/3613—General characteristics of the apparatus related to heating or cooling by body heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
- A61M2207/10—Device therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0507—Electrodes for the digestive system
- A61N1/0514—Electrodes for the urinary tract
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F10/00—Additive manufacturing of workpieces or articles from metallic powder
- B22F10/20—Direct sintering or melting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F2999/00—Aspects linked to processes or compositions used in powder metallurgy
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B19/00—Programme-control systems
- G05B19/02—Programme-control systems electric
- G05B19/18—Numerical control [NC], i.e. automatically operating machines, in particular machine tools, e.g. in a manufacturing environment, so as to execute positioning, movement or co-ordinated operations by means of programme data in numerical form
- G05B19/4097—Numerical control [NC], i.e. automatically operating machines, in particular machine tools, e.g. in a manufacturing environment, so as to execute positioning, movement or co-ordinated operations by means of programme data in numerical form characterised by using design data to control NC machines, e.g. CAD/CAM
- G05B19/4099—Surface or curve machining, making 3D objects, e.g. desktop manufacturing
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F30/00—Computer-aided design [CAD]
- G06F30/20—Design optimisation, verification or simulation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P10/00—Technologies related to metal processing
- Y02P10/25—Process efficiency
Definitions
- the invention discloses a pelvic cavity endoscopic external stent implanted by surgery. It is used to improve the physiological function and function caused by the internal organs deficiency caused by the internal organs. It involves human senile diseases, Chinese doctors' internal gas theory and medical records, Western doctors understand the anatomy and surgical stent implantation technology, and medical three-dimensional printing technology. field. In the well-known theory of doctors, there is a discussion that "the lack of gas will cause the internal organs to fall down.” The lack of gas in life is mostly caused by the age of people after the age of 50. It is a life course that everyone cannot overcome. "Zhongqi" is one of the definitions of the Chinese doctor's science in "internal gas”.
- the gas in the coke is not just the spleen and stomach.
- the "qi" of the inner air is written as: ⁇ , which is different from the gas of breath and the gas phase of the grain, indicating that the material of the life level of " ⁇ ” exists objectively in human life (the following uses "qi” to represent the ⁇ character) And act on the whole process of human life.
- the source of internal gas is called vitality, which is congenital; the vitality is the life fuel given by nature when a certain characteristic life originates. The quality and quantity of the vitality is determined from the moment when the living body exists. It is exhausted with age, and the lack of gas is a quantitative phase before the exhaustion of the vitality.
- the present invention relates to the well-known Western doctor's understanding of the section, and the theory does not recognize the objective existence of the "qi" living substance in human life. Therefore, the lesions of the epigenetic group are separated and characterized. Although there is a definition of senile syndrome, only the phenomenological lesions can be treated according to anatomical classification, and the blood sputum caused by poor blood circulation of various organs is attributed to local inflammation. Targeted drugs lead to necrosis of directional organs. When applied to a broad-spectrum drug, it causes side-effect damage. The dysfunction after surgical removal of necrotic tissue symptoms cannot be avoided, indicating that its scientific nature is obviously insufficient, and the basic theory is wrong, resulting in diagnosis and treatment errors. .
- the present invention relates to well-known stenting techniques and methods for stenting in Western medicine. Since the Western medical community did not correctly recognize the group lesions in the abdominal cavity during the prior art before the present invention, the surgical stent implantation technique does not use the expertise and method of pelvic endoscopic stent implantation.
- the present invention relates to the field of medical tomography and three-dimensional data reconstruction techniques and three-dimensional three-dimensional printing technology, and uses a known printing technique of medical metal, ceramic and plastic materials to manufacture a personalized pelvic bladder endoscopic stent.
- the closest to the creation of the present invention is the intraurethral stent implantation technique in the urinary system case, which is achieved by implanting a metal stent directly into the urethra from the outer urethra to expand the prostate and the internal and external sphincter internal urethra.
- the inadequacy is the loss of function of the prostate and internal and external sphincters, the sense of abnormality is obvious, easy to be infected, can not eliminate the group of lesions in the abdominal cavity, and the condition of the deterioration of the auto-ecology can not be improved.
- Intraurethral stent implantation techniques do not involve techniques and methods for abdominal surgery.
- the invention raises the bladder by implanting the external bladder stent in the pelvic cavity, so that the internal and external sphincters, the prostate and the urethra are no longer subjected to the squeezing to restore the original physiological functions, and the independent ecological functions of other organs are improved and restored, and the group is effectively eliminated.
- the lesions correct the errors in the understanding of the syndrome of the elderly defined in the pathology of Western medicine.
- the well-known metal stent in the bladder urethra completely loses the contraction and closure function of the urethra in an open infection state. Its expansion force forces the male prostate to squeeze the rectum, while the female urethra directly squeezes the rectum, which causes difficulty in excretion of the feces and rectum. Prolapse.
- the metal stent in the urethra only serves to artificially expand the urethra to release urine.
- the well-known virtual reality technology is the pelvic cavity of the invention, and the external stent and the implantation method are realized by the characteristic individual belly.
- the cavity structure 3D data virtual pelvic environment simulation method to verify the bladder reduction surgery program provides the basic theory and basic hardware.
- the object of the present invention is to provide a pelvic cavity endoscopic stent and an implantation method, which can reduce the organ in the abdominal cavity, eliminate the crush injury of the pelvic viscera, restore the physiological function of each organ, and effectively improve The quality of life and longevity of human beings in old age.
- the theory of the internal organs of the Chinese medicine is used to study the effective elimination of the five lesions in the pelvic cavity. And the method of implanting the front end fixed to the pelvic pubic comb to raise the lower body to eliminate the crush damage of the pelvic visceral organs below the bladder, and to achieve the recovery of the organ function.
- Preparation of the pelvic cavity endoscopic stent The abdominal tomography data is converted into three-dimensional data using a well-known medical three-dimensional printing technology solution, and the prototype design parameters of the pelvic cavity external support in the pelvic cavity are completely matched by the three-dimensional modeling software.
- the overall structure of the pelvic cavity bladder outer stent is assembled by two left and right pelvic cavity bladder outer stents and bridges with the same mirror image structure; the left and right pelvic cavity bladder outer stents with the same mirror image structure are provided with pubic combs.
- the bridge plate and the bridge plate pubic symphysis gap, the bridge fixing hole, the bladder seat and the decompression arc; the front end of the bridge plate connects the pubic comb on the hook, the rear end connects the bladder seat, and the bridge plate is arranged into a frame-like surface
- the front end is provided with a pubic symphysis gap, and the pubic comb is provided with a hook along the outer side of the nick.
- the pubic comb is provided with an injection channel input hole and a screw hole along the hook surface; a bridge fixing hole is arranged inside the pubic symphysis; the bladder seat is arranged In a funnel shape conforming to the structure of the bladder neck, the funnel-shaped central decompression arc is arranged to avoid the shape of the bladder sphincter, and the injection channel output hole is arranged on the arc surface; the decompression arc is set on the cross section of the bridge between the hooks on the pubic comb
- the two chucks are coupled with the two bridge fixing holes to fix the left and right pelvic cavity inner bladder outer brackets into a whole body.
- the overall structure of the pelvic cavity and the outer support is assembled by the left and right pelvic cystic bladder outer stents and bridges with the same mirror image structure; the left and right pelvic cavity of the bladder with the same mirror structure are connected with the pubic bone at the front end.
- the surface is provided with a screw hole
- the pubic comb is connected to the outside of the pubic symphysis gap at the front end of the bridge plate along the hook
- the pubic comb is provided with an injection channel input hole along the upper portion of the hook
- the screw is provided in the input hole of the injection channel
- a pubic symphysis gap is connected to the inner side of the front end of the plate, and a bridge fixing hole is arranged on the plane of the bridge plate at the pubic symphysis
- the bladder seat is connected to the rear end of the bridge plate, and the bladder seat is arranged in a funnel shape conforming to the bladder neck structure, and the funnel-shaped center is reduced.
- the arc is arranged to avoid the shape of the bladder sphincter, and the injection channel output hole is arranged on the decompression arc surface;
- the bridge plate is arranged as a frame curved structure;
- the injection channel output hole on the decompression arc surface is injected through the bridge plate section
- the channel is connected to the pubic comb along the hook injection channel input hole, and the screw at the input end of the injection channel is used to connect the sealing screw, the electrode or deliver the drug In vitro ligation;
- a gate-shaped bridge arranged to meet cuboid deck surface, are connected to both ends of a flat rectangular parallelepiped having a chuck fall prevention structure;
- bladder pelvic cavity bottom left outer bracket The piece is connected to one end of the bridge through the fixing hole, and the other end of the connecting bridge is connected to the right piece of the bladder bottom outer bracket in the pelvic cavity through the fixing hole, and is connected into the outer pelvic cavity inner bladder outer bracket;
- the characteristic abdominal data was collected using a tomography device: the pelvic cavity end of the bladder was printed and replaced with a medical three-dimensional printer.
- a tomographic device Prior to implantation, a tomographic device was used to collect characteristic personal abdominal data; according to the well-known Wu Jieping urology, "the bladder position of the newborn is higher than that of the adult, and the urethral opening can reach the level of the upper edge of the pubic symphysis, most of which is located in the abdominal cavity. Even in the In the empty state, the top of the bladder is still above the level of the upper edge of the pubic symphysis. As the age increases, the bladder will gradually fall into the pelvis and reach the position of the person around puberty.” The description begins with the human body standing abdominal cavity tomography scan to obtain the dirty.
- the pelvic cavity endoscopic stent is placed under the pubic ligament and between the pubic comb and the pubic comb, outside the pubic symphysis, between the bladder outsole and the external sphincter.
- the implantation method is surgical abdominal stent implantation.
- the liquid medicine is injected from the injection channel input hole, and after the gas is discharged from the output hole, the input hole is sealed with a special screw.
- the screw mouth ensures that the drug solution can only ooze out from the injection channel output hole when the body fluid is inflated with body temperature; and then the surgical procedure of the bladder reduction is performed according to the preoperative verification, and the pubic ligament and the pubic comb are removed without damage.
- the pubic comb can be implanted in the gap along the hook to avoid the pubic symphysis;
- the male then removes the non-invasive tissue between the bladder outsole and the external sphincter, the posterior part of the bladder outsole and the ampulla of the vas deferens, and makes a gap in the bladder seat implanted at the posterior end of the bladder end of the pelvic cavity;
- the female removes the already shrinking uterus according to the known medical case, sutures the vaginal opening and the peritoneum, so that the upper space of the bladder is released, and then the non-destructive peeling is created at the junction of the posterior edge of the outer base of the bladder and the outer wall of the vagina.
- Vaginal truncation and peeling ensure that the bladder seat end can be implanted and the required lifting space, and then suture the vaginal cutoff; the front edge of the bladder bottom and the pubic and pubic comb joints should avoid the clitoris tissue when making non-destructive peeling, and ensure the left and right pelvic cavity
- the inner bladder bottom outer stent is not pressed against the clitoris tissue when it is connected in a non-contact state;
- Post-operative treatment is performed according to a known abdominal surgery protocol.
- the above-mentioned decompression arc to the pubic comb is provided with an injection channel in the cross section of the bridge between the hooks; when the injection channel is used as a drug slow release body, a part of the liquid medicine can be saved, and the liquid medicine automatically exudes from the output hole when the body temperature expands with body temperature. When the pressure inside and outside the injection channel is equal, the oozing stops automatically.
- the input channel end of the injection channel is provided with a screw; when the connector is installed at the screw, the drug can be injected from the outside of the body to the outer position of the bladder.
- the above-mentioned injection channel input hole is provided with a screw; when the external connector is installed at the screw, it can be used as an electrode for applying a physical method.
- the above-mentioned three-dimensional data virtual pelvic environment simulation is used to verify the bladder reduction operation plan by using the characteristic personal abdominal cavity structure.
- the specific method is to construct a plurality of VR virtual three-dimensional eyes and tactile surgical instruments on the virtual operating table software interactive platform by using the well-known virtual reality technology.
- the synthetic surgery simulation engineering system the surgical operator exercises the bladder reduction surgery program in the virtual reality environment through the surgical simulation engineering system until the best method and effect are obtained.
- the pelvic cavity endoscopic stent and implantation method of the invention can correct the existing erroneous disease recognition and treatment plan in the field of senile diseases, correctly carry forward and develop the theoretical and practical achievements of Chinese medicine, and reduce the social medical resources and waste of funds caused by mistakes. And can effectively improve the quality of life and confidence of life in the human age.
- the pelvic cavity endoscopic stent and implantation method of the present invention should be used. Eliminate group lesions, and substantially improve and improve the quality of life of middle-aged and elderly people.
- the pelvic intraluminal external stent and implantation method designed by the invention can lift the bladder to the upper position of the pubic bone to prevent the abdominal internal organs from falling and restore the functions of various organs.
- the funnel-shaped central decompression arc ensures the release of the pressure of the falling gravity on the internal and external sphincters, so that the parasympathetic nerves return to normal perception and signal transmission function, no longer squeeze the male prostate, urethra and rectum, female urethra and rectum, effectively alleviate Or eliminate the group of urinary and associated system lesions, restore excretory function.
- the new support upper part restores the transverse colon to the original upper posterior position.
- the jejunum and small intestine are returned, the peritoneum is decompressed, the hernia is eliminated, and the compression force on the bladder is effectively reduced.
- the increase in space has gradually restored the urine storage to the original level.
- the new upper support supports the pancreas and kidneys to eliminate the downward force caused by gravity, and the shape and function are restored.
- the paroxysmal urine sugar and paroxysmal uremia gradually disappear.
- the new upper part of the support causes the gallbladder and the liver to remove the downward force caused by gravity.
- the shape and function of the elongated gallbladder are restored, and the uncooked bile is no longer overflowing.
- the bladder head space is restored, and the volume of urine is increased and recovered when the urine is filled.
- the urine backtracking increases the intrarenal pressure.
- the phenomenon disappears;
- the bladder seat bears the role of supporting the bladder.
- the space released by the central decompression arc makes the internal and external sphincters of the bladder no longer bear the weight when the bladder is squeezed.
- the urine-sensing ability and nerve conduction control function are restored, the urine is short, the urine is frequent, and the urine is urinary.
- the bladder After the bladder is lifted to the upper position of the pubic bone, the lower prostate space is restored, the shape is restored, the blood circulation is smoothed, the blood stasis is quickly metabolized, the inflammation and hypertrophy symptoms are eliminated, the internal urethra is restored, and the urinary retention symptoms are eliminated.
- the urine no additional effort is exerted, the symptoms of hernia are eliminated; the function of the urethral gland and the ejaculatory duct is restored, and the ejaculation-type sexual dysfunction and the irritability caused by it are eliminated.
- the frame structure of the pelvic cavity bladder outer stent is low in manufacturing cost, saves materials, is firm and light, and has high matching precision.
- the gas permeable structure can prevent infection and tissue necrosis caused by body fluid retention at the contact site.
- the injection channel inside the frame structure of the pelvic cavity bladder outer stent has the function of transporting and storing the drug solution.
- the drug can be injected from the outside to the outer bottom of the bladder; when the injection channel is used as a drug release body At the time, some of the liquid medicine can be saved, and the liquid medicine is automatically discharged from the output hole when it is swollen with body temperature.
- the connector can also be used as an electrode for applying physical methods after the connector is installed at the screw end.
- Figure 1 is a schematic illustration of a group lesion schedule of the present invention.
- Fig. 2 is a schematic view showing the overall structure of the pelvic cavity outer bladder stent of the present invention.
- Fig. 3 is a top plan view showing the assembly of the pelvic cavity bladder outer stent of the present invention.
- Fig. 4 is a top plan view showing the left piece of the pelvic cavity endless stent of the present invention.
- Fig. 5 is a partial structural view showing the screw hole in the input hole of the injection channel of the pelvic cavity outer stent in the pelvic cavity of the present invention.
- Fig. 6 is a schematic view showing the structure of a bridge of a bladder bottom outer stent of the pelvic cavity of the present invention.
- the pelvic cavity bladder outer stent and the implantation method to eliminate.
- Wu Jieping urology "the bladder position of the newborn is higher than that of the adult, and the urethral opening can reach the level of the upper edge of the pubic symphysis, and most of it is located in the abdominal cavity. Even if the top of the bladder is in the empty state, it is still above the level of the upper edge of the pubic symphysis.
- the description uses a tomographic scanner to collect characteristic personal abdominal data before implantation.
- the data acquisition method of the pelvic cavity external bladder stent includes: firstly, the human body standing body position abdominal cavity tomography scan, obtain the three-dimensional spatial position data when the organ is completely dropped; and then do the human body supine tilting 20-40 degree angular position abdominal cavity tomography scan, The three-dimensional spatial position data of the adult prepubertal organ was not simulated, and the three-dimensional database of the characteristic individual abdominal cavity structure was generated, and then converted into a three-dimensional modeling software data format, and the pelvic cavity was created after modifying the characteristic abdominal cavity structure model and modifying the prototype design parameters.
- the internal bladder bottom outer stent model file verifies the bladder reduction surgical plan by characterizing the individual abdominal cavity three-dimensional data virtual pelvic environment simulation; the method is to construct a plurality of VR virtual three-dimensional eyes and tactile surgical instruments on the virtual operating table using well-known virtual reality technology.
- the surgical simulation engineering system is integrated, and the surgical operator exercises the bladder reduction surgery program in the virtual reality environment through the surgical simulation engineering system until the best method and effect are obtained.
- Obtain all the safe operation data of the validated bladder reduction surgery program including the three-dimensional spatial position data and geometric shape data when each organ is completely dropped, the three-dimensional spatial position data and geometric shape data of each organ can be lifted), and then raise according to the determination.
- the medical nano-ceramic material and the preparation process are selected, and the pelvic cavity bladder outer stent of the frame structure is printed by the medical-grade three-dimensional printer.
- the parameters include the spatial position in the pelvic cavity, the pelvis and organ shape data; according to the characteristics of the individual abdominal cavity structure data model (including the data of the two models of the falling state and the post-lift state), through the surgical simulation of the engineering system in virtual reality
- the environmentally-operated bladder reduction surgery program obtained validated safe operation data, and then modified the prototype design parameters of the bladder-outer stent in the pelvic cavity to generate a virtual pelvic bladder-outer stent.
- This virtual pelvic cavity endoscopic stent was then brought into the surgery simulation system environment to repeat the exercise of the bladder reduction surgery in the virtual reality environment until the implantation operation was all smooth, and the virtual pelvic cavity was completely completed.
- the model file of the pelvic cavity bladder external support model that is, the pelvic cavity bladder base stent model data.
- the overall structure of the external bladder of the pelvic cavity is composed of two left and right 1-L pelvic cavity outer bladder stents and a bridge 6; the pelvic cavity
- the inner bladder bottom outer stent structure is provided with a pubic comb along the hook 9 and the screw hole 10, the bridge plate 7 and the bridge plate pubic bone joint gap, the bridge fixing hole 8, the bladder seat 2 and the decompression arc 3; the pubic comb is hooked on the hook
- the curved structure has a hook shape, one side of the curved surface is connected to the front end of the bridge plate, and the rear end of the bridge plate is connected to the bladder seat; the pubic comb is placed on the outer side of the pubic symphysis gap of the bridge plate, and the pubic comb is provided with an injection along the hook surface.
- the channel input hole 5 and the screw port 5-2; the bridge plate 7 is arranged in a mesh curved surface structure, and the front end is provided with a pubic symphysis gap, the pubic joint gap is provided with a bridge fixing hole 8 on the plane of the bridge plate, and the back end is provided with a bladder seat 2, the bladder seat is set to conform to the funnel shape of the bladder neck structure,
- the funnel-shaped central decompression arc 3 is arranged to avoid the shape of the bladder sphincter, and the injection channel output hole 4 is arranged on the arc surface; the injection channel connection input hole 5 and the output hole 4 are arranged in the bridge plate section.
- the anterior and posterior pelvic cavity of the same anterior pelvic cavity is connected with a pubic comb along the hook (used to buckle the pubic comb from the pubic comb), and the surface is provided with a screw hole (for the pelvic cavity)
- the bottom outer bracket and the pubic comb are firmly positioned.
- the pubic comb is connected to the outer side of the pubic symphysis in the front end of the bridge.
- the pubic comb is provided with an injection channel input hole along the upper portion of the hook, and a screw hole is arranged in the input hole of the injection channel;
- a pubic symphysis gap is connected to the inner side of the front end, a bridge fixing hole is arranged at the pubic joint gap;
- a bladder seat is connected to the rear end of the bridge plate, and the bladder seat is arranged in a funnel shape conforming to the bladder neck structure, and the decompression arc of the funnel-shaped center is set to avoid
- the bladder sphincter shape is opened, and the injection channel output hole is arranged on the decompression arc surface;
- the bridge plate is arranged as a frame curved structure; the injection channel output hole on the decompression arc surface is connected to the pubic comb through the injection channel provided in the bridge plate section
- Upper hook injection channel input hole, screw port of injection channel input hole end is used to connect sealing screw, electrode or external connector for drug delivery;
- bridge is set to The door-shaped rectangular parallele
- the pubic comb is integrated with the hook, the bridge plate and the bladder seat.
- the rectangular parallelepiped and the chuck of the bridge form a door-shaped rectangular structure, that is, the door frame structure of the house; the lower plane of the rectangular parallelepiped coincides with the curved surface formed by the connection of the two bridge plates, the upper and lower planes are parallel; the upper plane and all the vertical planes
- the angle is guided into an arc; the ends of the lower plane of the rectangular parallelepiped are respectively connected with a chuck having an anti-drop structure.
- the characteristic symmetry angle of the personal pubic comb the angle formed by the two bridge plates connected by the bridge is obtained.
- the throat tube 5-1 is placed on the pubic comb along the surface of the hook.
- the throat tube 5-1 is a part of the injection channel, the diameter is the same, and the screw port 5-2 is connected outside the throat tube for setting electrodes or delivering drugs.
- Body connector is a part of the injection channel, the diameter is the same, and the screw port 5-2 is connected outside the throat tube for setting electrodes or delivering drugs.
- the bridge 6 is arranged to conform to the curved structure of the left and right bridge plates to form a curved door structure 6-1 structure, which is molded by using nylon plastic with the same elasticity and strength as the pubic ligament.
- a chuck 6-2 having an anti-shedding structure is respectively disposed on the planes of both ends of the rectangular parallelepiped above the gate structure. The two chucks are fixedly connected with the two bridge fixing holes to ensure a fixed gap between the left and right symmetrical sides of the bladder bottom outer bracket in the pelvic cavity.
- the implantation method is surgical abdominal stent implantation.
- the liquid medicine is injected from the injection channel input hole, and after the gas is discharged from the output hole, the input hole is sealed with a special screw.
- the screw mouth ensures that the drug solution can only ooze out from the injection channel output hole when the body fluid is inflated with body temperature; and then the surgical procedure of the bladder reduction is performed according to the preoperative verification, and the pubic ligament and the pubic comb are removed without damage.
- the pubic comb can be implanted in the gap along the hook to avoid the pubic symphysis;
- the male then removes the non-invasive tissue between the bladder outsole and the external sphincter, the posterior part of the bladder outsole and the ampulla of the vas deferens, and makes a gap in the bladder seat implanted at the posterior end of the bladder end of the pelvic cavity;
- the female removes the already shrinking uterus according to the known medical case, sutures the vaginal opening and the peritoneum, so that the upper space of the bladder is released, and then the non-destructive peeling is created at the junction of the posterior edge of the outer base of the bladder and the outer wall of the vagina.
- Vaginal truncation and peeling ensure that the bladder seat can be implanted and the required lifting space, and then suture the vaginal cutoff; the bladder bottom leading edge and shame
- the clitoris tissue should be avoided to ensure that there is no space for the left and right pelvic cavity in the non-contact state.
- the medical electric drill is positioned according to the screw hole provided on the pubic comb along the hook curved surface, and the medical countersunk screw fixes the bladder bottom outer bracket of the pelvic cavity to the outer side of the pubic comb to ensure that the screw cap cannot have protrusion;
- the chucks at both ends of the bridge are respectively inserted into the two fixing holes on the left and right sides of the front end of the bridge plate to ensure that the left and right bladder bottom outer brackets are connected and fixed in a non-contact state;
- the postoperative treatment is performed according to a known abdominal surgery program.
- the drug can be injected from the outside of the body to the outer bottom of the bladder; when the injection channel is used as a drug release body, a part of the drug solution can be saved, and the drug is injected into the sealed connector to ensure that the drug solution is inflated with body temperature. It can only ooze out from the output hole, and the oozing will stop automatically when the pressure inside and outside the injection channel is equal.
- the connector can be used as an electrode for applying a physical method after the connector is installed at the screw of the injection channel input hole.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Medical Informatics (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Mechanical Engineering (AREA)
- High Energy & Nuclear Physics (AREA)
- Data Mining & Analysis (AREA)
- Biophysics (AREA)
- Databases & Information Systems (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (7)
- 骨盆腔内膀胱底外支架,其特征在于:骨盆腔内膀胱底外支架的整体结构由镜像结构相同的左右两片骨盆腔内膀胱底外支架和桥接器组装成型;镜像结构相同的左右两片骨盆腔内膀胱底外支架设置有耻骨梳上沿钩和螺钉孔,桥板和桥板耻骨联合缺口,桥接器固定孔,膀胱座和减压弧;桥板前端连接耻骨梳上沿钩,后端连接膀胱座,桥板设置成框架状曲面结构;前端设置有耻骨联合缺口,缺口外侧设置耻骨梳上沿钩,耻骨梳上沿钩曲面上设置有注射通道输入孔和螺钉孔;耻骨联合缺口处内侧设置有桥接器固定孔;膀胱座设置成符合膀胱颈结构的漏斗状,漏斗状的中心减压弧设置成避开膀胱括约肌形状,弧面上设置有注射通道输出孔;减压弧至耻骨梳上沿钩之间桥板断面中设置有注射通道,注射通道输入孔端设置有螺口,用于设置密封螺丝、电极或输送药物的体外连接器;桥接器设置成符合桥板曲面的门形长方体结构,长方体两端平面上分别设置一个具有防脱落结构的卡头;两卡头与两个桥接器固定孔配合连接固定左右两片骨盆腔内膀胱底外支架成整体。
- 骨盆腔内膀胱底外支架,其特征在于:骨盆腔内膀肮底外支架的整体结构由镜像结构相同的左右两片骨盆胱内膀胱底外支架和桥接器组装成型;镜像结构相同的左右两片骨盆腔内膀胱底外支架前端连接有耻骨梳上沿钩,曲面上设置有螺钉孔,耻骨梳上沿钩连接桥板前端耻骨联合缺口外侧,耻骨梳上沿钩上部设置有注射通道输入孔,注射通道输入孔内设置有螺口;桥板前端内侧连接有耻骨联合缺口,耻骨联合缺口处设置有桥接器固定孔;桥板后端连接有膀胱座,膀胱座设置成符合膀胱颈结构的漏斗状,漏斗状中心的减压弧设置成避开膀胱括约肌形状,减压弧弧面上设置有注射通道输出孔;桥板设置成框架曲面结构;减压弧弧面上的注射通道输出孔通过桥板断面中设置的注射通道连接到耻骨梳上沿钩注射通道输入孔,注射通道输入孔端的螺口用于连接密封螺丝、电极或输送药物的体外连接器;桥接器设置成符合桥板曲面的门形长方体结构,长方体两端平面上分别连接一个具有防脱落结构的卡头;骨盆腔内膀胱底外支架左片通过固定孔连接桥接器一端,连接桥接器另一端通过固定孔连接骨盆腔内膀胱底外支架右片,连接成整体骨盆腔内膀胱底外支架。
- 根据权利要求1或2所述的骨盆腔内膀胱底外支架,其特征在于:使用断层扫描装置采集特征个人腹腔数据;再用医用三维立体打印机打印成型的骨盆腔内膀胱底外支架备用。
- 根据权利要求1或2所述的骨盆腔内膀胱底外支架,其特征在于:所述减压弧弧面上的注射通道输出孔至耻骨梳上沿钩注射通道输入孔之间桥板断面中设置有注射通道:当注射通道作为药物缓释体时可以储蓄部分药液,药液随体温热胀时自动从输出孔渗出,当注射通道内外压相等后自动停止渗出;注射通道输入孔内设置有螺口;当螺口处安装连接器后可以注入药物直达膀胱底外部:注射通道输入孔内设置有螺口;当螺口处安装连接器后能够作为施用物理方法的电极使用。
- 根据权利要求1或2所述的骨盆腔内膀胱底外支架的植入方法,其特征在于包括以下步骤:植入前使用断层扫描装置采集特征个人腹腔数据;首先做人体站立体位腹腔断层扫描,获得脏器完全下坠时的三维空间位置数据;再做人体仰卧倒倾20~40度角体位腹腔断层扫描,获得模拟成人青春期前脏器未下坠时的三维空间位置数据,生成特征个人腹腔构造三维数据库,再转换成三维建模软件数据格式,创建该特征个人腹腔构造模型和修改原型设计参数后的骨盆腔内膀胱底外支架模型文件,通过特征个人腹腔构造三维数据虚拟骨盆环境模拟验证膀胱复位手术方案后,用医用三维立体打印机打印成型备用;手术操作人员需通过特征个人腹腔构造模型和修改原型设计参数后的膀胱外支架模型的打印件实习,获得验证地膀胱复位手术方案安全操作的全部数据。
- 根据权利要求5所述的骨盆腔内膀胱底外支架的植入方法,其特征在于:骨盆腔内膀胱底外支架的植入位置在耻骨梳韧带下与耻骨梳上沿和耻骨梳外侧面,耻骨联合部位外侧,到膀胱外底和外括约肌之间;植入方法为外科腹腔支架植入手术,在公知的腹腔手术方案做术前无菌处置完成后,把药液从注射通道输入孔注入,待输出孔无气体排出后,用专用螺丝密封输入孔螺口,保证术后药液随体温热胀时只能从注射通道输出孔渗出;再按术前验证地膀胱复位手术方案操作,对耻骨梳韧带与耻骨梳上沿进行无损伤组织剥离做出骨盆腔内膀胱底外支架的耻骨梳上沿钩可以植入的间隙,避开耻骨联合部位;男性再对膀胱外底和外括约肌之间,膀胱外底后部与输精管壶腹之间进行无损伤组织剥离,做出骨盆腔内膀胱底外支架后端的膀胱座植入的间隙;女性按公知医案摘除已经萎缩的子宫,缝合阴道内口和腹膜,使膀胱上部空间得到释放,再在膀胱外底后缘与阴道外壁连接处做无损剥离创建间隔,无法剥离者需要在此做阴道截断剥离保证膀胱座端能够植入和所需提升空间,再缝合阴道截断处开口;膀胱底前缘与耻骨、耻骨梳连接处做无损剥离时要避开阴蒂组织,保证左右两片骨盆腔内膀胱底外支架呈非接触状态连接固定时不压迫阴蒂组织;分别将左右两片骨盆腔内膀胱底外支架沿耻骨梳上沿间隙插入,使耻骨梳上沿钩与左右耻骨梳上沿和外侧面完全吻合,使膀胱座与膀胱外底完全吻合并准确避开内括约肌;用医用电钻按耻骨梳上沿钩曲面设置的螺钉孔定位打孔,将医用螺钉把骨盆腔内膀胱底外支架固定到耻骨梳外侧面上,保证螺丝帽没有突起;再将打印成的桥接器两端的卡头分别按进桥板前端左右两个固定孔中,保证左右两片骨盆腔内膀胱底外支架之间呈非接触状态连接固定;植入完成需按公知的腹腔手术方案做术后处置。
- 根据权利要求5所述的骨盆腔内膀胱底外支架的植入方法,其特征在于:减压弧至耻骨梳上沿钩之间桥板断面中设置有注射通道;当注射通道作为药物缓释体时可以储蓄部分药液,药液随体温热胀时自动从输出孔渗出,当注射通道内外压相等后自动停止渗出;注射通道输入孔端设置有螺口;当螺口处安装连接器后可从体外注入药物直达膀胱外底 部位;注射通道输入孔设置有螺口;当螺口处安装体外连接器后能够作为施用物理方法的电极使用;通过特征个人腹腔构造三维数据虚拟骨盆环境模拟验证膀胱复位手术方案,具体方法是使用公知的虚拟现实技术,将多个VR虚拟三维眼睛和触感手术器具构建在虚拟手术台软件互动平台上,整合成手术模拟工程系统,手术操作人员通过手术模拟工程系统在虚拟现实环境内演习膀胱复位手术方案,直至得到最佳方法和效果。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/304,088 US10952835B2 (en) | 2016-05-30 | 2017-05-25 | Intra-pelvic fundus vesicae support and method for implanting same |
JP2019516043A JP6689556B2 (ja) | 2016-05-30 | 2017-05-25 | 骨盤腔内の膀胱底外のステントおよびその植え込み方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610365490.4 | 2016-05-30 | ||
CN201610365490.4A CN105769380B (zh) | 2016-05-30 | 2016-05-30 | 骨盆腔内膀胱底外支架和植入方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017206783A1 true WO2017206783A1 (zh) | 2017-12-07 |
Family
ID=56375356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2017/085812 WO2017206783A1 (zh) | 2016-05-30 | 2017-05-25 | 骨盆腔内膀胱底外支架和植入方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US10952835B2 (zh) |
JP (1) | JP6689556B2 (zh) |
CN (1) | CN105769380B (zh) |
WO (1) | WO2017206783A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105769380B (zh) * | 2016-05-30 | 2017-09-22 | 周建 | 骨盆腔内膀胱底外支架和植入方法 |
CN106781957A (zh) * | 2017-01-09 | 2017-05-31 | 天津大学 | 男性盆腔器官群实体模型的制作方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101268970A (zh) * | 2007-12-18 | 2008-09-24 | 中国人民解放军第四军医大学 | 多轴向组配式抗感染半骨盆假体 |
US20150025308A1 (en) * | 2013-07-18 | 2015-01-22 | Boston Scientific Scimed, Inc. | Bodily implant |
CN104981220A (zh) * | 2013-02-08 | 2015-10-14 | 沃尔德玛链接有限公司 | 局部置换人盆骨的内置假体 |
CN105012048A (zh) * | 2014-04-18 | 2015-11-04 | 林鹤雄 | 支撑骨盆器官脱垂的植入物 |
CN105769380A (zh) * | 2016-05-30 | 2016-07-20 | 周建 | 骨盆腔内膀胱底外支架和植入方法 |
CN206080765U (zh) * | 2016-05-30 | 2017-04-12 | 周建 | 骨盆腔内膀胱底外支架 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4888022A (en) * | 1985-12-30 | 1989-12-19 | Huebsch Donald L | Endoprosthesis |
FR2724313A1 (fr) * | 1994-09-12 | 1996-03-15 | Peters | Prothese retzius plastie pour cure d'incontinence urinaire d'effort chez la femme |
US5785640A (en) * | 1996-05-23 | 1998-07-28 | Kresch; Arnold J. | Method for treating female incontinence |
IL127481A (en) * | 1998-10-06 | 2004-05-12 | Bio Control Medical Ltd | Urine excretion prevention device |
DE10056169C2 (de) * | 2000-11-13 | 2003-07-03 | Ethicon Gmbh | Implantat zum Halten der weiblichen Harnblase |
JP4241389B2 (ja) * | 2002-03-01 | 2009-03-18 | エチコン、インコーポレイテッド | 女性患者の骨盤器官脱出症処置のための方法および装置 |
WO2003094784A2 (en) * | 2002-05-07 | 2003-11-20 | Ams Research Corporation | Urethral prosthesis with tensioning member |
US20040193228A1 (en) * | 2003-03-31 | 2004-09-30 | Gerber Martin T. | Method, system and device for treating various disorders of the pelvic floor by electrical stimulation of the left and right pudendal nerves |
US20050234291A1 (en) * | 2004-03-30 | 2005-10-20 | Peter Gingras | Medical device |
US8047982B2 (en) * | 2004-05-07 | 2011-11-01 | Ethicon, Inc. | Mesh tape with wing-like extensions for treating female urinary incontinence |
WO2005123184A2 (en) * | 2004-06-10 | 2005-12-29 | Ndi Medical, Llc | System and method for treating incontinence with implantation in adipose tissue |
EP1853344A4 (en) * | 2005-03-02 | 2008-05-28 | Continence Control Systems Int | IMPROVED METHOD AND DEVICE FOR TREATING INCONTINENCE |
US7878969B2 (en) * | 2005-07-25 | 2011-02-01 | Boston Scientific Scimed, Inc. | Pelvic floor repair system |
US20070100388A1 (en) * | 2005-10-31 | 2007-05-03 | Medtronic, Inc. | Implantable medical device providing adaptive neurostimulation therapy for incontinence |
US20080021263A1 (en) * | 2006-07-20 | 2008-01-24 | Antoni Castello Escude | Implantable mechanical device that have the ability to apply traction to organs or anatomical tissues for its reposition during and after a surgical intervention |
CA2653253C (en) * | 2006-07-25 | 2014-03-18 | Ams Research Corporation | Surgical articles and methods for treating pelvic conditions |
ES2528664T3 (es) * | 2006-08-02 | 2015-02-11 | Cousin Biotech, S.A.S. | Hamaca suburetral |
CA2686136A1 (en) * | 2007-04-28 | 2008-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Dynamic and adjustable support devices |
EP2160149B1 (en) * | 2007-06-11 | 2016-04-13 | ConTIPI Medical Ltd. | Adjustable tension ring for amelioration of urinary incontinence in females |
US10307597B2 (en) * | 2007-10-11 | 2019-06-04 | Peter Forsell | Method for controlling flow of urine in a patient's urethra, ureter, renal pelvis or bladder |
US8870743B2 (en) * | 2008-04-08 | 2014-10-28 | Boston Scientific Scimed, Inc. | Pelvic floor mesh and incontinence sling |
WO2010083086A1 (en) * | 2009-01-14 | 2010-07-22 | Cardiac Pacemakers, Inc. | Promoting diuresis and natriuresis by applying electric field |
KR101063358B1 (ko) * | 2010-03-05 | 2011-09-07 | 이정윤 | 폐쇄공하 긴장전환장치 |
US9326839B2 (en) * | 2010-03-05 | 2016-05-03 | Jeong Yoon YI | Infra-obturator tension transfer device |
US20130053688A1 (en) * | 2010-05-13 | 2013-02-28 | Ams Research Corporation | Implantable mechanical support |
WO2011156286A2 (en) * | 2010-06-07 | 2011-12-15 | Medtronic, Inc. | Stimulation therapy for bladder dysfunction |
WO2012134689A1 (en) * | 2011-03-28 | 2012-10-04 | Ams Research Corporation | Implants, tools, and methods for treatments of pelvic conditions |
US9492259B2 (en) * | 2011-03-30 | 2016-11-15 | Astora Women's Health, Llc | Expandable implant system |
WO2013003714A1 (en) * | 2011-06-30 | 2013-01-03 | Ams Research Corporation | Implants, tools, and methods for treatments of pelvic conditions |
US20130006049A1 (en) * | 2011-06-30 | 2013-01-03 | Alexander James A | Implants, tools, and methods for treatments of pelvic conditions |
EP2757987A4 (en) * | 2011-09-22 | 2015-07-08 | Pelvalon Inc | INTRAVAGINAL DEVICES AND METHOD FOR THE TREATMENT OF CHILDREN'S INCONTINENCE |
AU2013331359B2 (en) * | 2012-10-16 | 2018-04-19 | Boston Scientific Scimed, Inc. | Tools and methods for treatment of pelvic conditions |
-
2016
- 2016-05-30 CN CN201610365490.4A patent/CN105769380B/zh active Active
-
2017
- 2017-05-25 JP JP2019516043A patent/JP6689556B2/ja active Active
- 2017-05-25 US US16/304,088 patent/US10952835B2/en active Active
- 2017-05-25 WO PCT/CN2017/085812 patent/WO2017206783A1/zh active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101268970A (zh) * | 2007-12-18 | 2008-09-24 | 中国人民解放军第四军医大学 | 多轴向组配式抗感染半骨盆假体 |
CN104981220A (zh) * | 2013-02-08 | 2015-10-14 | 沃尔德玛链接有限公司 | 局部置换人盆骨的内置假体 |
US20150025308A1 (en) * | 2013-07-18 | 2015-01-22 | Boston Scientific Scimed, Inc. | Bodily implant |
CN105012048A (zh) * | 2014-04-18 | 2015-11-04 | 林鹤雄 | 支撑骨盆器官脱垂的植入物 |
CN105769380A (zh) * | 2016-05-30 | 2016-07-20 | 周建 | 骨盆腔内膀胱底外支架和植入方法 |
CN206080765U (zh) * | 2016-05-30 | 2017-04-12 | 周建 | 骨盆腔内膀胱底外支架 |
Also Published As
Publication number | Publication date |
---|---|
CN105769380A (zh) | 2016-07-20 |
JP2019520959A (ja) | 2019-07-25 |
CN105769380B (zh) | 2017-09-22 |
JP6689556B2 (ja) | 2020-04-28 |
US20190358013A1 (en) | 2019-11-28 |
US10952835B2 (en) | 2021-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Levin | The mechanisms of human female sexual arousal | |
Palit et al. | The physiology of human defecation | |
BR112020020860A2 (pt) | Dispositivos, sistemas e métodos para treinamento dos músculos do assoalho pélvico | |
Hyman et al. | Ependymal cyst of the cervicodorsal region of the spinal cord | |
WO2017206783A1 (zh) | 骨盆腔内膀胱底外支架和植入方法 | |
CN105012048B (zh) | 支撑前阴道壁脱垂器官的植入物 | |
CN206080765U (zh) | 骨盆腔内膀胱底外支架 | |
Parente | Biomechanics of the Pelvic Floor during Vaginal delivery | |
CN1194713C (zh) | 抗衰老缩阴道美胸部壮阳器药物及生产方法 | |
Cuckow et al. | Bladder Exstrophy, Epispadias, and Cloacal Exstrophy | |
Wah et al. | Pelvic Floor Support | |
RU2539188C1 (ru) | Способ лечения энкопреза | |
Chaturvedi et al. | Ayurvedic Treatment Protocol in Prasramsini Yoni Vyapat (Second Degree Uterine Prolapse) | |
Kalpdev et al. | Neovagina creation: a new method using disposable syringe mold with Interceed | |
RU2209043C1 (ru) | Способ вагинопроктоаносфинктеропластики при лечении клоакальных атрезий заднего прохода | |
US20110226258A1 (en) | Uterus Implant | |
Crankson et al. | Female bladder exstrophy | |
Stuhldreher et al. | Bladder exstrophy: Considerations and management of the newborn patient | |
Lau | IMPROVE SEXUAL FUNCTION WITH VAGINAL REJUVENATION SURGERY | |
Vishwanath | Textbook of Obstetrics-E-Book | |
Freedman | Functional constipation: a conservative first line approach | |
Kothawale et al. | AYURVEDIC ASPECT OF PELVIC ORGAN PROLAPSE-A REVIEW | |
Bernorio et al. | Women's sexual pain disorders; a clinical sexological profile | |
Komisaruk et al. | Neurology and sex | |
King | American eclectic obstetrics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17805728 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019516043 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 05.02.2019) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17805728 Country of ref document: EP Kind code of ref document: A1 |